Riociguat, CAS 625115-55-1

Product Description: Riociguat is an oral stimulator of soluble guanylate cyclase (sGC) used in the treatment of pulmonary hypertension.

Applications: COVID-19-immunoregulation

Formula: C20H19FN8O2

References: [1]Schermuly RT, et al. Expression and function of soluble guanylate cyclase in pulmonary arterial hypertension. Eur Respir J. 2008 Oct;32(4):881-91./[2]Schermuly RT, et al. Riociguat for the treatment of pulmonary hypertension. Expert Opin Investig Drugs. 2011 Apr;20(4):567-76./[3]Donda K, et al. Riociguat prevents hyperoxia-induced lung injury and pulmonary hypertension in neonatal rats without effects on long bone growth. PLoS One. 2018 Jul 10;13(7):e0199927.

CAS Number: 625115-55-1

Molecular Weight: 422.42

Compound Purity: 99.58

Research Area: Cardiovascular Disease

Solubility: DMSO : 20 mg/mL (ultrasonic)

Target: Guanylate Cyclase

• Artikelnummer: MEXHY-14779-25
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-14779-25
• Verpackungseinheit: 25 mg
• Mengeneinheit: STK